Recent studies have found that CtBP1 is highly expressed and mislocalized in metastatic prostate cancer, and reducing the expression level of CtBP1 can significantly inhibit prostate cancer proliferation and metastasis in vivo and in vitro [66]. The gene discussed is CTBP1; the disease is prostate carcinoma.